IMCR
$54.58
Revenue | $105.64Mn |
Net Profits | $-26.42Mn |
Net Profit Margins | -25.01% |
Immunocore Holdings Plc-adr’s revenue jumped 137.16% since last year same period to $105.64Mn in the Q4 2023. On a quarterly growth basis, Immunocore Holdings Plc-adr has generated 105.16% jump in its revenue since last 3-months.
Immunocore Holdings Plc-adr’s net profit fell -58.21% since last year same period to $-26.42Mn in the Q4 2023. On a quarterly growth basis, Immunocore Holdings Plc-adr has generated -1487.45% fall in its net profits since last 3-months.
Immunocore Holdings Plc-adr’s net profit margin jumped 33.29% since last year same period to -25.01% in the Q4 2023. On a quarterly growth basis, Immunocore Holdings Plc-adr has generated -776.26% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.36 |
EPS Estimate Current Year | -0.36 |
Immunocore Holdings Plc-adr’s earning per share (EPS) estimates for the current quarter stand at -0.36 - a 98.34% jump from last quarter’s estimates.
Immunocore Holdings Plc-adr’s earning per share (EPS) estimates for the current year stand at -0.36.
Earning Per Share (EPS) | -32.22 |
Immunocore Holdings Plc-adr’s earning per share (EPS) jumped 40.33% since last year same period to -32.22 in the Q4 2023. This indicates that the Immunocore Holdings Plc-adr has generated 40.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-07 | -28.92 | 4 | 113.83% |
2023-08-10 | -32.1 | -0.37 | 98.85% |
2023-03-31 | -32.19 | -35 | -8.73% |
2024-02-28 | -21.74 | -32.22 | -48.21% |